石药集团只能往外跑了

财讯先锋
02 Mar

作者 | 骆亦辉编辑 | 吴玮近日,石药集团发布2024年度盈利预警,预计截至2024年12月31日的公司拥有人应占溢利将较2023年同期的58.73亿元减少约26%。整体看来石药集团表现不及预期,同时集团在国际授权业务方面的新动向也备受关注。事实上,这家老牌制药企业正面临转型与突围的关键时刻。01不难发现,药品集采政策对石药集团的业绩产生了显著冲击。根据公司公告,抗肿瘤药物 中津优力 及 多美素...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10